P-335: A formative evaluation of dietetic non-medical prescribing in paediatric diabetes
C TriggAbstract
Introduction
Since 2016, UK dietitians have been eligible to qualify as Non-Medical Prescribers which allows them to prescribe medicines, such as Insulin. Despite increasing policy support for dietetic non-medical prescribing (NMP), no published evidence currently describes implementation of dietetic NMP within paediatric diabetes services. This study explored organisational factors influencing implementation, including stakeholder perceptions, perceived benefits and barriers, to inform future service development.
Objectives
To evaluate stakeholder perceptions of dietetic NMP within a paediatric diabetes service, identifying perceived benefits, barriers and implementation enablers.
Methods
A mixed-methods questionnaire comprising 15 quantitative and qualitative questions was developed following stakeholder mapping, logic modelling and quality improvement planning. The questionnaire was distributed via Microsoft Forms to multidisciplinary stakeholders across a single Welsh Health Board. Quantitative data were analysed descriptively and qualitative responses underwent pragmatic thematic analysis.
Results
Twelve responses were received from dietitians, paediatric diabetes specialist nurses, consultant paediatricians, pharmacists and senior managers. Participants viewed dietitians as well placed to undertake NMP and anticipated improvements in service efficiency, timeliness of insulin treatment decisions and patient experience. Perceived barriers inlcuded governance arrangements, workforce capacity, organisational culture and limited understanding of prescribing models. Key enablers were robust governance, multidisaplinary collborations, leadership engagement and organisational support.
Conclusions
Successful implementation of dietetic NMP in paediatric diabetes depends on organisational readiness rather than clinical capability. These findings provide an evidence-informed foundation to support future implementation and contribute to the emerging evidence base for innovative models that improve access to specialist care.